Mutational Anatomy of an HIV-1 Protease Variant Conferring Cross-resistance to Protease Inhibitors in Clinical Trials
Open Access
- 1 December 1996
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 271 (50) , 31957-31963
- https://doi.org/10.1074/jbc.271.50.31957
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Three-dimensional Structure of a Mutant HIV-1 Protease Displaying Cross-resistance to All Protease Inhibitors in Clinical TrialsPublished by Elsevier ,1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.Proceedings of the National Academy of Sciences, 1995
- Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzymeJournal of the American Chemical Society, 1995
- L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease InhibitorJournal of Medicinal Chemistry, 1994
- Dissociation and association of the HIV-1 protease dimer subunits: Equilibria and ratesBiochemistry, 1994
- Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinaseAntiviral Research, 1991
- Comparison of the HIV‐1 and HIV‐2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag‐Pol polyproteinsFEBS Letters, 1991
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985
- Solid-Phase Peptide Synthesis. III. An Improved Synthesis of Bradykinin*Biochemistry, 1964